Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Dec 02, 2020 9:26am
282 Views
Post# 32016921

RE:This great news will be coming this month

RE:This great news will be coming this monthYes I think we are in store for some positive news.

It's funny, last week on the pullback I tried to buy some on the bid at $0.185 and was there all day before deciding to just pay $0.19. Today there was very little bid so I joined again at $0.185 for a small amount and now it looks like it will open at $0.20.

Who knows if it means anything but I think people are anxious to buy this and will even if costs them a few pennies waiting to do so.

We just need that one bit of news.


pista1 wrote: Theralase's patented and proprietary PDCs, specifically TLD-1433. Currently, the UM research is completing the preclinical (in-vitro) stage. Theralase plans to commence an in vivo small animal study later this year at another facility equipped to handle SARS-CoV-2 viruses and, if successful, commence human clinical studies in 2021.


<< Previous
Bullboard Posts
Next >>